These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
793 related articles for article (PubMed ID: 9639410)
41. Molecular analysis of the INK4 family of genes in prostate carcinomas. Park DJ; Wilczynski SP; Pham EY; Miller CW; Koeffler HP J Urol; 1997 May; 157(5):1995-9. PubMed ID: 9112579 [TBL] [Abstract][Full Text] [Related]
42. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Batova A; Diccianni MB; Yu JC; Nobori T; Link MP; Pullen J; Yu AL Cancer Res; 1997 Mar; 57(5):832-6. PubMed ID: 9041181 [TBL] [Abstract][Full Text] [Related]
43. Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma. Koduru PR; Zariwala M; Soni M; Gong JZ; Xiong Y; Broome JD Blood; 1995 Oct; 86(8):2900-5. PubMed ID: 7579381 [TBL] [Abstract][Full Text] [Related]
44. Mutational analysis of the p15 and p16 genes in acute leukaemias. Sill H; Aguiar RC; Schmidt H; Hochhaus A; Goldman JM; Cross NC Br J Haematol; 1996 Mar; 92(3):681-3. PubMed ID: 8616035 [TBL] [Abstract][Full Text] [Related]
45. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Elenitoba-Johnson KS; Gascoyne RD; Lim MS; Chhanabai M; Jaffe ES; Raffeld M Blood; 1998 Jun; 91(12):4677-85. PubMed ID: 9616165 [TBL] [Abstract][Full Text] [Related]
47. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors. Zariwala M; Xiong Y Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552 [TBL] [Abstract][Full Text] [Related]
48. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622 [TBL] [Abstract][Full Text] [Related]
49. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan. Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670 [TBL] [Abstract][Full Text] [Related]
50. [Homozygous deletion and methylation of p16 and p15 gene in acute leukemia]. Chen W; Zhang W; Zhu J Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):474-6. PubMed ID: 11721412 [TBL] [Abstract][Full Text] [Related]
51. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma. Chim CS; Wong KY; Loong F; Lam WW; Srivastava G Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658 [TBL] [Abstract][Full Text] [Related]
52. Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions. Diccianni MB; Batova A; Yu J; Vu T; Pullen J; Amylon M; Pollock BH; Yu AL Leuk Res; 1997 Jun; 21(6):549-58. PubMed ID: 9279366 [TBL] [Abstract][Full Text] [Related]
53. Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma. Tasaka T; Berenson J; Vescio R; Hirama T; Miller CW; Nagai M; Takahara J; Koeffler HP Br J Haematol; 1997 Jan; 96(1):98-102. PubMed ID: 9012694 [TBL] [Abstract][Full Text] [Related]
54. p16 is a major inactivation target in hepatocellular carcinoma. Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001 [TBL] [Abstract][Full Text] [Related]
55. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Kovar H; Jug G; Aryee DN; Zoubek A; Ambros P; Gruber B; Windhager R; Gadner H Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981 [TBL] [Abstract][Full Text] [Related]
56. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas. Ogino A; Yoshino A; Katayama Y; Watanabe T; Ota T; Komine C; Yokoyama T; Fukushima T J Neuropathol Exp Neurol; 2005 May; 64(5):398-403. PubMed ID: 15892297 [TBL] [Abstract][Full Text] [Related]
57. Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines. Gemma A; Takenoshita S; Hagiwara K; Okamoto A; Spillare EA; McMemamin MG; Hussain SP; Forrester K; Zariwala M; Xiong Y; Harris CC Int J Cancer; 1996 Nov; 68(5):605-11. PubMed ID: 8938142 [TBL] [Abstract][Full Text] [Related]
58. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas. Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056 [TBL] [Abstract][Full Text] [Related]
59. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Hatta Y; Hirama T; Miller CW; Yamada Y; Tomonaga M; Koeffler HP Blood; 1995 May; 85(10):2699-704. PubMed ID: 7742529 [TBL] [Abstract][Full Text] [Related]
60. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. Tahara H; Smith AP; Gaz RD; Arnold A J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]